Immunovant Ownership | Who Owns Immunovant?

Overview Forecast RevenueFinancials Chart

Immunovant Ownership Summary

Immunovant is owned by 51.93% institutional investors, 58.10% insiders. Fmr is the largest institutional shareholder, holding 8.94% of IMVT shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 3.34% of its assets in Immunovant shares.

IMVT Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Immunovant	51.93%	58.10%	-10.03%
Sector	Healthcare Stocks	57.39%	9.93%	32.68%
Industry	Biotech Stocks	68.48%	9.65%	21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Fmr	13.10M	8.94%	$324.44M
Vanguard group	6.68M	4.56%	$165.45M
Deep track capital, lp	6.00M	4.10%	$148.62M
Blackrock	4.92M	3.56%	$129.79M
Blackrock funding, inc. /de	5.14M	3.51%	$127.39M
T. rowe price investment management	5.12M	3.49%	$126.75M
Armistice capital	3.87M	2.64%	$95.87M
State street	2.72M	1.97%	$71.78M
Alpine global management	2.16M	1.47%	$53.48M
Perceptive advisors	2.14M	1.46%	$52.99M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Alpine global management	2.16M	12.58%	$53.48M
Stempoint capital lp	1.12M	6.92%	$27.71M
Deep track capital, lp	6.00M	5.54%	$148.62M
Adar1 capital management	787.48K	3.90%	$19.51M
Two seas capital lp	1.51M	3.24%	$37.44M
Tyro capital management	250.62K	3.00%	$6.62M
Prosight management, lp	325.00K	2.56%	$8.58M
Perceptive advisors	2.14M	1.46%	$52.99M
Armistice capital	3.87M	1.31%	$95.87M
Boxer capital	825.00K	1.15%	$21.78M

Top Buyers

Holder	Shares	% Assets	Change
T. rowe price investment management	5.12M	0.08%	1.79M
Deep track capital, lp	6.00M	5.54%	1.65M
Jpmorgan chase	1.15M	0.00%	925.08K
Two seas capital lp	1.51M	3.24%	835.00K
Norges bank	637.95K	0.00%	637.95K

Top Sellers

Holder	Shares	% Assets	Change
Point72 asset management	-	-	-1.38M
Paradigm biocapital advisors lp	-	-	-1.36M
Capital research global investors	-	-	-976.24K
State street	2.72M	0.00%	-922.95K
Viking global investors lp	1.41M	0.11%	-913.61K

New Positions

Holder	Shares	% Assets	Change	Value
Norges bank	637.95K	0.00%	637.95K	$15.80M
Bnp paribas arbitrage, snc	85.20K	0.00%	85.20K	$2.11M
Orbimed advisors	78.50K	0.04%	78.50K	$1.94M
Aquatic capital management	47.65K	0.03%	47.65K	$1.18M
Vestal point capital, lp	45.00K	0.07%	45.00K	$1.11M

Sold Out

Holder	Change
Reuter james wealth management	-1.00
Capital performance advisors llp	-3.00
Nelson, van denburg & campbell wealth management group	-11.00
Cibc private wealth group	-17.00
Bessemer group	-50.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2024	197	-3.90%	76,056,919	-3.29%	51	1.80%	100	5.26%	58	-9.38%
Sep 30, 2024	204	-4.23%	78,645,357	5.27%	53	2.05%	94	-14.55%	64	-
Jun 30, 2024	211	-10.21%	74,707,025	7.20%	54	2.33%	109	0.93%	63	-23.17%
Mar 31, 2024	235	-7.11%	69,688,195	1.94%	48	2.16%	108	-20.00%	82	3.80%
Dec 31, 2023	253	18.22%	68,360,172	2.16%	47	1.80%	135	1.50%	79	71.74%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Fidelity Growth Compy Commingled Pl S	5.68M	3.34%	404.20K
Fidelity Growth Compy Commingled Pl O	4.45M	3.04%	196.00K
Fidelity Growth Company Fund	4.06M	2.39%	313.10K
T. Rowe Price Small-Cap Stock	2.41M	1.42%	165.21K
T. Rowe Price US Small-Cap Core Equity	2.41M	1.42%	313.66K
Vanguard US Total Market Shares ETF	2.12M	1.25%	2.26K
Vanguard Total Stock Mkt Idx Inv	2.10M	1.24%	14.18K
SPDR® S&P Biotech ETF	1.70M	1.00%	-18.23K
Vanguard Small Cap Index	1.69M	1.00%	7.26K
iShares Russell 2000 ETF	1.53M	0.90%	-13.26K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Apr 23, 2025	Stout Jay S	Chief Technology Officer	Sell	$28.47K
Apr 23, 2025	Geffner Michael	Chief Medical Officer	Sell	$34.74K
Apr 16, 2025	Barnett Eva Renee	Chief Financial Officer	Sell	$44.57K
Apr 16, 2025	Salzmann Peter	Chief Executive Officer	Sell	$123.90K
Apr 09, 2025	Salzmann Peter	Chief Executive Officer	Sell	$364.94K

Insider Transactions Trends

Date	Buy	Sell
2025 Q2	-	5
2025 Q1	1	17
2024 Q4	-	16
2024 Q3	-	28
2024 Q2	-	23

IMVT Ownership FAQ

Who Owns Immunovant?

Immunovant shareholders are primarily institutional investors at 51.93%, followed by 58.10% insiders and -10.03% retail investors. The average institutional ownership in Immunovant's industry, Biotech Stocks , is 68.48%, which Immunovant falls below.

Who owns the most shares of Immunovant?

Immunovant’s largest shareholders are Fmr (13.1M shares, 8.94%), Vanguard group (6.68M shares, 4.56%), and Deep track capital, lp (6M shares, 4.10%). Together, they hold 17.60% of Immunovant’s total shares outstanding.

Does Blackrock own Immunovant?

Yes, BlackRock owns 3.56% of Immunovant, totaling 4.92M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 129.79M$. In the last quarter, BlackRock increased its holdings by 439.33K shares, a 9.81% change.

Who is Immunovant’s biggest shareholder by percentage of total assets invested?

Alpine global management is Immunovant’s biggest shareholder by percentage of total assets invested, with 12.58% of its assets in 2.16M Immunovant shares, valued at 53.48M$.

Who is the top mutual fund holder of Immunovant shares?

Fidelity Growth Compy Commingled Pl S is the top mutual fund holder of Immunovant shares, with 3.34% of its total shares outstanding invested in 5.68M Immunovant shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools